Keisuke Nagai

Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation

I. Kumagai, A. Kuwahara, T. Nakanishi, 2020, International journal of molecular sciences.

Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity

K. Makabe, I. Kumagai, T. Kumagai, 2018, Oncotarget.

Domain order of a bispecific diabody dramatically enhances its antitumor activity beyond structural format conversion: the case of the hEx3 diabody.

M. Unno, T. Kudo, I. Kumagai, 2013, Protein engineering, design & selection : PEDS.